IDT
IDT Australia Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
2
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
IDT Australia Ltd. produces, develops and supplies pharmaceutical products. The company is headquartered in Melbourne, Victoria. The firm is engaged in the supply of products and provision of research and development and other technical services within the pharmaceutical and allied industries. Its business includes research and development, active pharmaceutical ingredient (API) and finished dosage form manufacture (FDF), clinical and commercial, project management, chemical services, analytical chemistry, pharmacy services, pharmaceutical development in all dosage forms, clinical packaging and regulatory affairs services. Its Current Good Manufacturing Practice (cGMP) manufacturing facilities can produce both API and FDF positioning it as a facility in the medicinal cannabis manufacturing space. The company also provides a full-scale service for new drug development and scale-up, commercial active drug manufacture as well as a variety of oral and injectable finished drug dose forms. Its analytical laboratories offer medicinal cannabis cGMP testing.
📈 Performance
Price History
-76.18%
1M
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.09
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in IDT
2
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in IDT
852 days
IDT investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
33%
50k - 100k
67%
Less than 50k
👶 Age of investors
18 - 25
26 - 34
50%
35 - 90
50%
🙋 Legal gender of investors
Female
100%
Male
Pearlers who invest in IDT also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
📊 Share price
$90.18 AUD
NULL AUSTRALIA
NULL BETA
Little Green Pharma Ltd. produces medicinal cannabis products for sale to Australian patients. The company is headquartered in Perth, Western Australia. The company went IPO on 2020-02-20. The firm has two global production sites for the manufacture of its own-branded and white-label ranges of Good Manufacturing Practice (GMP)-grade medicinal cannabis products, being a 21,500 square meters cultivation and 4,000 square meters GMP manufacturing facility capable of producing over 30 tons of medicinal cannabis biomass per annum located in Denmark (EU) and an indoor cultivation and manufacturing facility located in Western Australia capable of producing three tons of medicinal cannabis biomass per annum. The firm focuses on patient access in the global medicinal cannabis market and is actively engaged in promoting education and outreach programs, as well as participating in clinical investigations and research projects to develop new delivery systems.
📊 Share price
$0.17 AUD
VHY.AX was created on 2011-05-26 by Vanguard. The fund's investment portfolio concentrates primarily on high dividend yield equity. Vanguard Australian Shares High Yield ETF seeks to track the return of the FTSE Australia High Dividend Yield Index before taking into account fees, expenses and tax.
📊 Share price
$66.86 AUD
NULL AUSTRALIA
NULL BETA
NULL INCOME
Althea Group Holdings Ltd. is an investment company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2018-09-21. The firm services these sectors via two business units: Althea and Peak Processing Solutions. Althea is its pharmaceutical business that offers a range of cannabis-based medicines which are made available to patients via prescription. Althea offers a range of education, access, and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways. Peak Processing Solutions is its recreational cannabis business, which produces legal cannabis products purchased by adult consumers in retail stores. Peak Processing Solutions provides formulation and mass-manufacturing of recreational cannabis products, including beverages, concentrates, topicals and others. The firm operates in regulated and legal cannabis markets across Europe, North America, Australia, and Africa.
📊 Share price
$0.05 AUD
ESGI.AX was created on 2018-03-06 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.
📊 Share price
$29.97 AUD
NULL GLOBAL
NULL SMART BETA
NULL ETHICAL
NULL THEMATIC
Want more shares? Try these...
